We believe that success in cell and gene therapy requires a strategic, integrated approach—one that combines scientific expertise with real-world commercial insight.
About Us
Our Approach
Our Approach
Unlike traditional CDMOs, we embed consultancy at every stage.
This ensures each therapy is designed for scalability, regulatory success, and long-term viability from the outset. By working collaboratively with our clients, we simplify complexity, de-risk development, and provide tailored, flexible solutions that adapt to the evolving needs of each therapy. Whether it’s CMC strategy, process development, GMP manufacturing, or facility design, our expertise helps innovators navigate challenges and accelerate therapies to market efficiently and cost-effectively.
With over 20 years of experience, a state-of-the-art GMP facility, and a deep commitment to partnership and transparency, we don’t just provide services—we become an extension of your team, guiding therapies from concept to commercialisation and ultimately, to the patients who need them.
Our Mission
We are driven by a shared purpose — to bring cost-effective, life-changing cell and gene therapies to patients faster. With a unique blend of consultancy expertise and CDMO capabilities under one roof, we walk alongside our clients at every step of the way. From concept to product release, we simplify complexity, de-risk development, and provide flexible, tailored solutions that empower innovators to succeed. We don’t just offer services; we become an extension of your team, committed to transparency, trust, and scientific excellence.
Our Vision
We envision a world where every groundbreaking cell and gene therapy reaches the patients who need it, without unnecessary delays, inefficiencies, or cost barriers. By redefining what it means to be a CDMO, we combine technical expertise with a truly collaborative approach, ensuring therapies move seamlessly from discovery to commercialisation. Through innovation, flexibility, and a deep commitment to our partners, we are shaping the future of advanced therapies and transforming lives.
Our Approach
Capability
eXmoor is backed by over 20 years experience helping 150 organisations on their manufacturing journey.
Trust
We work as part of your team, developing lasting relationships based on trust, transparency and openness.
Collaboration
We work side-by-side with you to complement, enhance and build your capabilities.
Our Services
Integrated Consultancy & CDMO Services
Unlike traditional CDMOs, our embedded consultancy provides strategic guidance at every stage, from CMC strategy to facility design, ensuring seamless scalability and regulatory compliance.
Learn More
Comprehensive Process Development
Our expertise encompasses process and analytical development for viral vectors, autologous and allogeneic cell therapies, and RNA technologies, facilitating efficient translation from research to clinical application.
Learn More
State-of-the-Art GMP Manufacturing
Our 65,000 ft² (6,000m²) GMP facility in Bristol is equipped with Grade C cleanrooms, dedicated QC labs, and fill-finish suites, supporting both clinical and commercial manufacturing needs.
Learn More
Tailored Facility Design & Engineering
With experience in designing over 45 CGT manufacturing facilities, we offer bespoke solutions that align with your commercial objectives, whether you require a custom-built facility or a fully managed site.
Learn More
Client-Centric Approach
Our consultants integrate seamlessly into your team, offering flexible, impartial, and industry-leading guidance. We prioritize your intellectual property rights, ensuring you maintain full control over your innovations.
Our Team
The eXmoor Pharma team has an unparalleled depth of experience in the Cell and Gene Therapy (CGT) sector, with hundreds of years of combined experience across all CGT manufacturing processes.
Let’s Accelerate Your Therapy Together
Choosing eXmoor Pharma means partnering with a team dedicated to accelerating your therapy’s journey from concept to patient, with a steadfast commitment to quality, innovation, and collaboration.